Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome-Reference-Cited by-同舟云学术

Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome

Published:2017-08-24 Issue:4 Volume:471 Page:521-530
ISSN:0945-6317
Container-title:Virchows Archiv
language:en
Short-container-title:Virchows Arch

Author:

Agopiantz Mikaël,Forgez Patricia,Casse Jean-Matthieu,Lacomme Stéphanie,Charra-Brunaud Claire,Clerc-Urmès Isabelle,Morel Olivier,Bonnet Céline,Guéant Jean-Louis,Vignaud Jean-Michel,Gompel Anne,Gauchotte Guillaume^ORCID

Funder

Agence Nationale de la Recherche

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/article/10.1007/s00428-017-2215-y/fulltext.html

Reference46 articles.

1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9–29. doi: 10.3322/caac.21208

2. Fleming GF, Brunetto VL, Cella D, Look KY, Reid GC, Munkarah AR, Kline R, Burger RA, Goodman A, Burks RT (2004) Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 22(11):2159–2166. doi: 10.1200/JCO.2004.07.184

3. Thigpen JT, Brady MF, Homesley HD, Malfetano J, DuBeshter B, Burger RA, Liao S (2004) Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 22(19):3902–3908. doi: 10.1200/JCO.2004.02.088

4. van Wijk FH, Aapro MS, Bolis G, Chevallier B, van der Burg ME, Poveda A, de Oliveira CF, Tumolo S, Scotto di Palumbo V, Piccart M, Franchi M, Zanaboni F, Lacave AJ, Fontanelli R, Favalli G, Zola P, Guastalla JP, Rosso R, Marth C, Nooij M, Presti M, Scarabelli C, Splinter TA, Ploch E, Beex LV, ten Bokkel HW, Forni M, Melpignano M, Blake P, Kerbrat P, Mendiola C, Cervantes A, Goupil A, Harper PG, Madronal C, Namer M, Scarfone G, Stoot JE, Teodorovic I, Coens C, Vergote I, Vermorken JB (2003) Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. Ann Oncol 14(3):441–448

5. Dupouy S, Viardot-Foucault V, Alifano M, Souaze F, Plu-Bureau G, Chaouat M, Lavaur A, Hugol D, Gespach C, Gompel A, Forgez P (2009) The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression. PLoS One 4(1):e4223. doi: 10.1371/journal.pone.0004223

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-4, IL-7, IL-9, NT, NRP1 May Be Useful Markers in the Diagnosis of Endometrial Cancer;Biomolecules;2024-09-01

2. Expressions of HuR, Methyl-HuR and Phospho-HuR in Endometrial Endometrioid Adenocarcinoma Are Associated with Clinical Features;International Journal of Molecular Sciences;2024-01-12

3. Neuron-derived neurotensin promotes pancreatic cancer invasiveness and gemcitabine resistance via the NTSR1/Akt pathway;American Journal of Cancer Research;2024

4. Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer;Aging;2023-09-05

5. Neurotensin and Its Involvement in Reproductive Functions: An Exhaustive Review of the Literature;International Journal of Molecular Sciences;2023-02-27